SCHEMBL30202833

SCHEMBL30202833

COC(=O)Cc1cncc(NC(=O)OC(C)(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 4/20 0.45
▸ NAMPT P43490 2/20 0.43
▸ CYP11B1 P15538 1/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ HSP90AB1 P08238 1/20 0.40
▸ PPARG P37231 2/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PTGDR2 Q9Y5Y4 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ TOP2A P11388 1/20 0.38
▸ TOP2B Q02880 1/20 0.38
▸ ATR Q13535 1/20 0.37
▸ DYRK1A Q13627 1/20 0.36
▸ MAPKAPK2 P49137 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24951504 1.00 CYP17A1 (0.45) CYP17A1NAMPTCYP11B1CYP11B2HSP90AB1
SCHEMBL15972019 0.85 CYP17A1 (0.48) CYP17A1NAMPTPTGDR2MAPK14TOP2A
SCHEMBL30530906 0.85 CYP17A1 (0.48) CYP17A1NAMPTPTGDR2MAPK14TOP2A
SCHEMBL18072998 0.83 NAMPT (0.48) CYP17A1NAMPTPTGDR2MAPK14TOP2A
SCHEMBL14428036 0.82 NAMPT (0.54) CYP17A1NAMPTMAPK14TOP2ATOP2B
SCHEMBL17916740 0.81 CYP17A1 (0.45) CYP17A1NAMPTPPARGPPARAMAPK14
SCHEMBL30530861 0.81 CYP17A1 (0.45) CYP17A1NAMPTPTGDR2MAPK14TOP2A
SCHEMBL20382968 0.80 HSP90AB1 (0.44) CYP17A1HSP90AB1PPARGPPARALMNA
SCHEMBL23592977 0.80 AURKA (0.47) CYP17A1PPARGLMNAMAPTSMN1; SMN2
SCHEMBL30489985 0.80 AURKA (0.47) CYP17A1PPARGLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4376845-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS Actelion Pharmaceuticals Ltd (CH) 2024-06-05 — — EP disclosed
WO-2023007009-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-02-02 — — WO disclosed
Send feedback